Walgreens Boots Alliance, Inc. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated condensed balance sheets

In millions of USD, except per-share amounts

	Q3 FY2025 As of May 31, 2025	Q2 FY2025 As of Feb 28, 2025	Q1 FY2025 As of Nov 30, 2024	Q4 FY2024 As of Aug 31, 2024	Q3 FY2024 As of May 31, 2024	Q2 FY2024 As of Feb 29, 2024	Q1 FY2024 As of Nov 30, 2023	Q4 FY2023 As of Aug 31, 2023	Q3 FY2023 As of May 31, 2023	Q2 FY2023 As of Feb 28, 2023	Q1 FY2023 As of Nov 30, 2022	Q4 FY2022 As of Aug 31, 2022	Q3 FY2022 As of May 31, 2022	Q2 FY2022 As of Feb 28, 2022	Q1 FY2022 As of Nov 30, 2021	Q4 FY2021 As of Aug 31, 2021	Q3 FY2021 As of May 31, 2021	Q2 FY2021 As of Feb 28, 2021	Q1 FY2021 As of Nov 30, 2020	Q4 FY2020 As of Aug 31, 2020
Assets
Current assets:
Cash and cash equivalents
Marketable securities
Accounts receivable, net
Inventories
Other current assets
Assets of discontinued operations - current (see Note 2)
Total current assets

Non-current assets:
Property, plant and equipment, net
Operating lease right-of-use assets
Goodwill
Intangible assets, net
Equity method investments (see Note 4)
Other non-current assets
Assets of discontinued operations - non-current (see Note 2)
Total non-current assets

Total assets
Liabilities, redeemable non-controlling interests and equity
Current liabilities:
Short-term debt
Trade accounts payable (see Note 14)
Operating lease obligations
Accrued expenses and other liabilities
Income taxes
Liabilities of discontinued operations - current (see Note 2)
Total current liabilities

Non-current liabilities:
Long-term debt
Operating lease obligations
Deferred income taxes
Accrued litigation obligations
Other non-current liabilities
Liabilities of discontinued operations - non-current (see Note 2)
Total non-current liabilities

Total liabilities
Redeemable non-controlling interests
Equity:
Preferred stock $.01 par value; authorized 32 million shares, none issued
Common stock $.01 par value; authorized 3.2 billion shares; issued 1,172,513,618 at May 31, 2023 and August 31, 2022
Common stock $.01 par value; authorized 3.2 billion shares; issued 1,172,513,618 shares at May 31, 2025 and 1,172,513,618 shares at August 31, 2024
Paid-in capital
Retained earnings
Accumulated other comprehensive loss
Treasury stock, at cost; 307,309,472 shares at May 31, 2025 and 308,513,185 shares at August 31, 2024
Total Walgreens Boots Alliance, Inc. shareholders’ equity
Non-controlling interests
Total equity
Total liabilities, redeemable non-controlling interests and equity

Comments